Embedded Files
Day 1
Nov 15, 2025
Nov 15, 2025
Registration 8:15 - 8:45
8:45 - 9:00
WCLL Discussion – Physicians Only
WCLL Discussion – Physicians Only
Drs Chen & Hoag
9:00 - 9:15
Opening Welcome
Opening Welcome
Drs Chen & Hoag
9:15 - 9:35
PCSK9 Inhibitors in Stroke Prevention
PCSK9 Inhibitors in Stroke Prevention
Dr. Jonathan Gabor
9:35 - 10:00
Challenging Case Study
Challenging Case Study
Dr. Peiman Marzban
Refreshment Break 10:00 - 10:20
10:20 -10:50
Obicetrapibe, Lipid lowering and dementia along with Apo E
Obicetrapibe, Lipid lowering and dementia along with Apo E
Dr. Gordon Hoag
10:50 - 11:20
Lp(a) level considered “risk for equivalent” for HeFH
Lp(a) level considered “risk for equivalent” for HeFH
Dr. Stephanie Gysel
11:20 - 12:00
HeFH genotyping, clinical criteria DLCN or Simon Broom or physician judgement
HeFH genotyping, clinical criteria DLCN or Simon Broom or physician judgement
Dr. Thang Nguyen
Lunch 12:00 - 13:00
13:00 - 13:30
Case Studies
Case Studies
And Role of Coronary Calcium score and CTCA, availability and appropriateness
And Role of Coronary Calcium score and CTCA, availability and appropriateness
Dr. James Stone
13:30 - 14:00
Availability of hsCRP and Lp(a), impact of provincial differences
Availability of hsCRP and Lp(a), impact of provincial differences
Drs Hoag & Chen
14:00 - 14:45
Pharma updates
Pharma updates
Sanofi
Ultragenyx
HLS Therapeutics
Novartis
Amgen
14:45 - 15:00
Summary Discussion & Next Meeting
Summary Discussion & Next Meeting
Meeting Adjournment
Page updated
Google Sites
Report abuse